GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM- salicylic acid lotion 
Chattem, Inc.

----------

Gold Bond Ultimate Multi-Symptom Psoriasis Relief Cream

Gold Bond Ultimate 
Multi-Symptom Psoriasis Relief Cream

Drug Facts

Active ingredient

Salicylic acid 3%

Purposes

Psoriasis, Seborrheic Dermatitis

Uses

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Warnings

For external use only

Ask a doctor before use if

  • condition covers a large area of the body

When using this product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

Apply to affected areas one to four times daily or as directed by a doctor

Inactive ingredients

water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

PRINCIPAL DISPLAY PANEL

GOLD BOND
ULTIMATE
Multi-Symptom
Psoriasis
Relief Cream
Net wT 4 oz (113 g)

PRINCIPAL DISPLAY PANEL
GOLD BOND
ULTIMATE
Multi-Symptom 
Psoriasis 
Relief Cream
Net wT 4 oz (113 g)

GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM 
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0412
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
HYDROXYETHYL UREA (UNII: MBQ7DDQ7AR)  
PETROLATUM (UNII: 4T6H12BN9U)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
STEARETH-21 (UNII: 53J3F32P58)  
HYDROGENATED JOJOBA OIL, RANDOMIZED (UNII: Q47ST02F58)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
SHEA BUTTER (UNII: K49155WL9Y)  
METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
7-DEHYDROCHOLESTEROL (UNII: BK1IU07GKF)  
LEVOMENOL (UNII: 24WE03BX2T)  
CETEARETH-25 (UNII: 8FA93U5T67)  
CORN OIL (UNII: 8470G57WFM)  
GINGER (UNII: C5529G5JPQ)  
CERAMIDE 3 (UNII: 4370DF050B)  
HYDROLYZED JOJOBA ESTERS (ACID FORM) (UNII: UDR641JW8W)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: W6000VEI5Y)  
MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
PANTHENOL (UNII: WV9CM0O67Z)  
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
CERAMIDE EOS (UNII: CR0J8RN66K)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
CERAMIDE 2 (UNII: C04977SRJ5)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
4-TERT-BUTYLCYCLOHEXANOL (UNII: K0H1405S9C)  
CERAMIDE 6 II (UNII: F1X8L2B00J)  
EDETIC ACID (UNII: 9G34HU7RV0)  
BEHENIC ACID (UNII: H390488X0A)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
N-HEXANOYLSPHINGOSINE (UNII: 038753E78J)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
TOCOPHEROL (UNII: R0ZB2556P8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-0412-221 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
2NDC:41167-0412-5113 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
3NDC:41167-0412-699 g in 1 TUBE; Type 0: Not a Combination Product01/01/201809/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03208/01/2016
Labeler - Chattem, Inc. (003336013)

Revised: 1/2024
Document Id: fa473fe8-04fa-4cf7-b03e-0fa8ae9dd1b0
Set id: b03e9f03-90f8-4f8c-9365-308931b08d1e
Version: 5
Effective Time: 20240110
 
Chattem, Inc.